Innovent Technologies, a pioneer in semiconductor contract manufacturing, is reshaping the industry by driving innovation, efficiency, and sustainability.

"Innovent and Roche link on lung cancer therapy development" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been ...

Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener Innovent ...

Focus on world-class technology platforms and key therapeutic areas Innovent Academy, the company's innovation engine, has built a world-class technology platform, encompassing ScFv engineering ...

Speaking at the Tata Technologies InnoVent Demo Day felicitation ceremony, Mr. Warren Harris, CEO & MD of Tata Technologies stated, "Tata Technologies vision of Engineering a better world embodies ...

Collectively, Synaffix’s nine biotech and pharma partners (including Genmab, Innovent Biologics, and Kyowa Kirin) have approximately 20 Synaffix technology-based ADCs in their pipelines ...

Innovent Academy, the company's innovation engine, has built a world-class technology platform, encompassing ScFv engineering, T cell engager (TCE), VHH bispecific antibodies, Topo1i ADC ...

SAN FRANCISCO and SUZHOU, China, Jan. 17, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

Amidst a backdrop of fluctuating global markets, the U.S. technology sector has faced notable volatility, driven by competitive pressures in artificial intelligence and mixed corporate earnings ...

Developed leveraging Innovent's proprietary novel topoisomerase 1 inhibitor (TOPO1i) platform, IBI3009 is one of the leading and potentially best-in-class DLL3-targeting ADCs. IBI3009 has shown ...